White Knight Strategic Wealth Advisors LLC grew its position in CVS Health Co. (NYSE:CVS - Free Report) by 176.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,740 shares of the pharmacy operator's stock after buying an additional 10,038 shares during the quarter. White Knight Strategic Wealth Advisors LLC's holdings in CVS Health were worth $707,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also modified their holdings of CVS. Stonebridge Financial Group LLC purchased a new stake in CVS Health during the 4th quarter worth about $28,000. Hopwood Financial Services Inc. purchased a new stake in CVS Health during the 4th quarter worth about $29,000. Financial Perspectives Inc lifted its holdings in CVS Health by 137.5% during the 4th quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock worth $36,000 after buying an additional 466 shares during the last quarter. Compass Planning Associates Inc purchased a new stake in shares of CVS Health in the 4th quarter valued at about $37,000. Finally, MidAtlantic Capital Management Inc. lifted its holdings in shares of CVS Health by 112.1% in the 4th quarter. MidAtlantic Capital Management Inc. now owns 827 shares of the pharmacy operator's stock valued at $37,000 after purchasing an additional 437 shares during the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling at CVS Health
In other CVS Health news, SVP James David Clark sold 7,513 shares of the firm's stock in a transaction that occurred on Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total value of $498,487.55. Following the sale, the senior vice president now owns 8,394 shares in the company, valued at approximately $556,941.90. This trade represents a 47.23% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.22% of the stock is owned by company insiders.
Analyst Ratings Changes
Several analysts have recently weighed in on CVS shares. Cowen reissued a "buy" rating on shares of CVS Health in a report on Monday, May 5th. Cantor Fitzgerald upgraded CVS Health from a "neutral" rating to an "overweight" rating in a research report on Wednesday, February 12th. Argus set a $77.00 price target on CVS Health in a research report on Tuesday, February 18th. Mizuho boosted their price target on CVS Health from $70.00 to $76.00 and gave the company an "outperform" rating in a research report on Wednesday, April 9th. Finally, Wolfe Research boosted their price target on CVS Health from 67.00 to 70.00 and gave the company an "overweight" rating in a research report on Tuesday, February 11th. Three investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $74.94.
Check Out Our Latest Analysis on CVS Health
CVS Health Stock Performance
NYSE CVS traded up $0.58 during trading hours on Friday, reaching $60.80. The company's stock had a trading volume of 8,141,495 shares, compared to its average volume of 11,331,066. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. The business has a 50-day simple moving average of $66.15 and a 200 day simple moving average of $59.41. CVS Health Co. has a 52 week low of $43.56 and a 52 week high of $72.51. The stock has a market cap of $76.91 billion, a PE ratio of 16.61, a PEG ratio of 0.98 and a beta of 0.60.
CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, beating the consensus estimate of $1.62 by $0.63. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. The company had revenue of $94.59 billion for the quarter, compared to analyst estimates of $93.07 billion. During the same quarter last year, the business earned $1.31 earnings per share. CVS Health's revenue was up 7.0% compared to the same quarter last year. Equities research analysts predict that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.
CVS Health Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd were paid a $0.665 dividend. The ex-dividend date of this dividend was Tuesday, April 22nd. This represents a $2.66 annualized dividend and a dividend yield of 4.38%. CVS Health's payout ratio is currently 63.48%.
CVS Health Company Profile
(
Free Report)
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Further Reading
Before you consider CVS Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.
While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
